ALPHA NK T Trademark
Trademark Overview
On Monday, April 8, 2024, a trademark application was filed for ALPHA NK T with the United States Patent and Trademark Office. The USPTO has given the ALPHA NK T trademark a serial number of 98488515. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, May 28, 2026. This trademark is owned by ImmunityBio, Inc.. The ALPHA NK T trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases for clinical, medicinal, therapeutic, vaccine and vaccine adjuvant purposes; pharmaceutical preparations and substances for the prevention of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, for clinical, medicinal, therapeutic, vaccine, and vaccine adjuvant purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases and animal diseases, namely, cancer, and infectious diseases; biological preparations for medical purposes, namely, in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment of human diseases and animal diseases, namely, ...
General Information
| Serial Number | 98488515 |
| Word Mark | ALPHA NK T |
| Filing Date | Monday, April 8, 2024 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, May 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 12, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and substances for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases for clinical, medicinal, therapeutic, vaccine and vaccine adjuvant purposes; pharmaceutical preparations and substances for the prevention of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases, for clinical, medicinal, therapeutic, vaccine, and vaccine adjuvant purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases and animal diseases, namely, cancer, and infectious diseases; biological preparations for medical purposes, namely, in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment of human diseases and animal diseases, namely, cancer, non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, infections, and infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 8, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ImmunityBio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
| Party Name | ImmunityBio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
Trademark Events
| Event Date | Event Description |
| Monday, April 8, 2024 | NEW APPLICATION ENTERED |
| Sunday, September 15, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 26, 2024 | ASSIGNED TO EXAMINER |
| Thursday, October 3, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 23, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 12, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 24, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, June 4, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 4, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, June 4, 2025 | SOU EXTENSION 1 GRANTED |
| Monday, September 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, December 7, 2025 | SOU TEAS EXTENSION RECEIVED |
| Sunday, December 7, 2025 | SOU EXTENSION 2 FILED |
| Sunday, December 7, 2025 | SOU EXTENSION 2 GRANTED |
| Monday, December 8, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 28, 2026 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 28, 2026 | SOU EXTENSION 3 FILED |
| Thursday, May 28, 2026 | SOU EXTENSION 3 GRANTED |
| Friday, May 29, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
